The Global Innovation Policy Center (GIPC) of the US Chambers of Commerce has recently released its International IP Index for Year 2019. In it, India has moved up 8 places to rank 36th among 50 ..
Compulsory license: GK, General Studies and Current Affairs
The U.S. administration accused India of infringing WTO norms by allowing Hyderabad-based Natco Pharma to produce a generic version of cancer drug Nexavar. The administration has called India’s move an ‘egregious’ violation of WTO norms. ..